Cargando…

P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

Detalles Bibliográficos
Autores principales:	Loschi, Michael, Rejto, Laszlo, Chuah, Hun, Caramella, Marianna, Hernández Rivas, Jesus, Sportoletti, Paolo, Dubruille, Viviane, Bellesso, Marcelo, Gröpper, Stefanie, Crodel, Carl, Qamoos, Hope, Socotch, Ashley, Huang, Zhuying, Wall, Sarah, Mcgreivy, Jesse, Rothbaum, Wayne P., Verstovsek, Srdan, Palandri, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431408/ http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd

Ejemplares similares

PB2198: TRIAL IN PROGRESS: AN OPEN-LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL-895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF)
por: Palandri, Francesca, et al.
Publicado: (2023)

S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (PTS)
por: Vachhani, Pankit, et al.
Publicado: (2023)

P1006: CHARACTERIZATION OF TL-895: A NOVEL BRUTON TYROSINE KINASE INHIBITOR (BTKI) IN CLINICAL DEVELOPMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MYELOFIBROSIS (MF)
por: Gulrajani, Michael, et al.
Publicado: (2023)

P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
por: Chary Nimmagadda, Subbaiah, et al.
Publicado: (2023)

S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX
por: Mascarenhas, John, et al.
Publicado: (2023)

PB2200: FOOD AND ACID REDUCING AGENT EFFECTS ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF THE COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) TL-895 IN HEALTHY SUBJECTS
por: Allard, Martine, et al.
Publicado: (2023)

The research for PLTS normalization method based on minimum entropy change and its application in MAGDM problem
por: Wu, Shouwen, et al.
Publicado: (2022)

The Predictive Values of MMP-9, PLTs, ESR, and CRP Levels in Kawasaki Disease with Cardiovascular Injury
por: Yang, Yinan, et al.
Publicado: (2022)

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
por: Mhibik, Maissa, et al.
Publicado: (2019)

1038. Edwardsiella tarda Bacteremia: Epidemiology, Clinical Features, and Outcomes
por: Kamiyama, Shinya, et al.
Publicado: (2018)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
por: Zamprogna, Giulia, et al.
Publicado: (2023)

Pion-Deuteron Coherent Scattering at 895 MeV/c
por: Bradamante, Franco, et al.
Publicado: (1968)

895. Prediction of Occurrence for Surgical Site Infection in Infected Surgeries
por: de Souza, Flávio Henrique Batista, et al.
Publicado: (2020)

POS-895 Post-COVID viral dermatoses and lupus patients
por: SAKAY, A., et al.
Publicado: (2022)

1685-1750 J.S. Bach. Organ Masterpieces. DM-2-1038

1038. Rapid Start: A Changing Algorithm for the Management of HIV Infection
por: Gudipati, Smitha, et al.
Publicado: (2020)

Hypothetical Protein gene1038 Contributes to Colistin Resistance in Aeromonas hydrophila
por: Liu, Junqi, et al.
Publicado: (2021)

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
por: Chen, Sunnia T., et al.
Publicado: (2022)

Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance
por: Liu, Shuozi, et al.
Publicado: (2022)

Prospective analysis of 895 patients on a UK Genomics Review Board
por: Moore, David Allan, et al.
Publicado: (2019)

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases
por: Bosman, Ariadne, et al.
Publicado: (2022)

Outcomes of 1038 Hip Arthroscopies: A Two-Year Follow-Up Study
por: Lodhia, Parth, et al.
Publicado: (2015)

Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
por: Bryer, Emily, et al.
Publicado: (2022)

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
por: Adam, Ishag, et al.
Publicado: (2022)

Targeting HDAC11 activity by FT895 restricts EV71 replication
por: Xie, Hong, et al.
Publicado: (2023)

P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF)
por: Clevenger, Tracy, et al.
Publicado: (2023)

The TENDL neutron data library and the TEND1038 38-group neutron constant system
por: Abramovich, S N, et al.
Publicado: (2001)

Environmental and occupational respiratory diseases – 1038. Efficacy of influenza vaccination on pediatric asthma control
por: Fazlollahi, Mohammad Reza, et al.
Publicado: (2013)

1038 Assesing the Management of Urinary Tract Infections at a Large, Urban Teaching Hospital
por: Advani, Shreena, et al.
Publicado: (2014)

1038. Impact of an Electronic Antibiotic Timeout on the Utilization of Frequently Prescribed Antibiotics in Hospitalized Patients
por: Drake, Ty C, et al.
Publicado: (2019)

Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis
por: Brem, Elizabeth A., et al.
Publicado: (2022)

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
por: Rankin, Katherine, et al.
Publicado: (2023)

Influences of genetic variants on stroke recovery: a meta-analysis of the 31,895 cases
por: Math, Nikhil, et al.
Publicado: (2019)

P1038: CLINICOPATHOLOGIC AND MOLECULAR CORRELATES OF ORGAN DAMAGE ACROSS THE SPECTRUM OF ADVANCED SYSTEMIC MASTOCYTOSIS
por: Liang, E., et al.
Publicado: (2022)

The Italian scenario, pts 1-2
por: Belloni, L
Publicado: (1987)

PTS: a pharmaceutical target seeker
por: Ding, Peng, et al.
Publicado: (2017)

Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients
por: Kuroda, Taira, et al.
Publicado: (2017)

Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B
por: Kumar, Deepak, et al.
Publicado: (2022)

895. Impact of Telemedicine on HIV Care and Prevention Services at an Academic Ryan White-Funded Clinic
por: Dasigi, Jay V, et al.
Publicado: (2021)

Predictors of Clinical Outcomes After Hip Arthroscopy: 5 Year Follow- Up Analysis of 1038 Patients
por: Domb, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ldmqig2m210cf1k61isftgko1